Wilshire Oncology Medical Group, Inc.
Wilshire Oncology Medical Group, Inc.
GLENDORA • WEST COVINA • RANCHO CUCAMONGA
POMONA • PASADENA • LA VERNE
endcap About Us middle Your Team middle Newly Diagnosed middle Types of Cancer middle Cancer Treatment middle Testing middle Cancer News middle Clinical Trials middle Support & Resources endcap
Message from the President Mission, Vision, Commitment Appointments Emergencies & Phone Calls Locations Common Questions Articles Privacy Practices Prescription Refills Patient Bill of Rights Privacy Policy Website Information
What is Cancer? Diagnosing Cancer Introduction to Cancer Treatment Optimizing Treatment Questions to Ask A Word about Clinical Trials Getting a Second Opinion The Role of Caregivers
General Cancer Information
Bladder Cancer Breast Cancer Cervical Cancer Colon Cancer Esophageal Cancer Gastric Cancer Head & Neck Cancer Hodgkin's Lymphoma Leukemia Lung Cancer Melanoma Multiple Myeloma Myelodysplastic Syndrome Non-Hodgkin's Lymphoma
More...
Ovarian Cancer Pancreatic Cancer Prostate Cancer Rectal Cancer Renal Cancer Uterine Cancer Testicular Cancer
Treatment Overview Chemotherapy Radiation Therapy Surgery Hormonal Therapy Biologic Therapy Stem Cell Transplantation Side Effects of Cancer Treatment Complementary & Alternative
Overview Screening Tools Diagnostic & Monitoring Tests
Latest News...
Anal Cancer Bladder Cancer Brain & CNS Breast Cancer Cervical Cancer Colon Cancer Complementary Alternative Medicine Esophageal Cancer Gastric Cancer Gene Therapy Head & Neck Cancer HIV Related Cancers Hodgkin's Lymphoma Leukemia
More...
Liver Cancer Lung Cancer - Non-Small Cell Lung Cancer - Small Cell Malignant Mesothelioma Melanoma Multiple Myeloma Myelodysplastic Syndromes Neuroblastoma Non-Hodgkin's Lymphoma Ovarian Cancer Pancreatic Cancer Prostate Cancer Rectal Cancer Renal Cancer Retinoblastoma
More...
Sarcoma Screening & Prevention Skin Cancer Stem Cell Transplant Supportive Care Testicular Cancer Thyroid Cancer Uterine Cancer Vaginal Cancer
Introduction What Are Clinical Trials? Phases Of Clinical Trials How Are Clinical Trials Conducted? Clinical Trials Safeguards Participating In Clinical Trials The Cost Of Clinical Trials Finding Specific Clinical Trials The Future Of Clinical Trials
Overview Caregivers Healing Environments Support Groups Journaling Birth Control and Sexuality Home Health Care Financial & Insurance Issues Advanced Directives Inspiration Movement & Exercise Life After Treatment Online Resources
floatmenu_left Home Home   Drug Dictionary Drug Dictionary   Cancer Dictionary Cancer Dictionary   Links Links   Contact Us Contact Us floatmenu_right
Wilshire Oncology Medical Group, Inc.
E-mail this page   Print this page
Section Title

Latest HIV Related Cancers - General News

Study Evaluates Impact of Highly Active Antiretroviral Therapy (HAART) on Cancer Risk in HIV-infected Men (8/10/2010)
Researchers reported that men infected with human immunodeficiency virus (HIV) are still at an increased risk of lymphoma, Kaposi’s sarcoma (KS), and anal cancer despite the introduction of highly active antiretroviral therapy (HAART).

Immunosuppression Increases Risk of HPV-related Cancers in AIDS Patients (8/20/2009)
The risk of HPV-related cancers is elevated among AIDS patients. This risk continues to increase as patients’ immune systems become more compromised, according to the results of a study published in the Journal of the National Cancer Institute.

Colorectal Cancer Screening for Individuals with HIV (8/24/2006)
According to an article recently published in the Archives of Internal Medicine, patients with the human immunodeficiency virus (HIV) over the age of 50 years may have a higher rate of colon cancer than healthy individuals and should be screened for this disease.

Addition of Rituxan® to CHOP Safe and Effective for AIDS-related NHL (8/16/2006)
According to an early online publication in the Journal of Clinical Oncology, the addition of Rituxan® (rituximab) to the chemotherapy combination known as CHOP is safe and effective for the treatment of AIDS-related non-Hodgkin's lymphoma.

Metastat® Shows Promise Against AIDS-related Kaposi’s Sarcoma (3/24/2006)
According to the results of a phase II clinical trial published in the Journal of Clinical Oncology, treatment with Metastat® (COL-3) reduced or eliminated detectable Kaposi’s sarcoma in some patients with acquired immune deficiency syndrome (AIDS).